PT98842A - PROCESS FOR THE PREPARATION OF N-SUBSTITUTED NON-SUBSTITUTED PHENYLALANYL AND PHYETHYLAMINE DERIVATIVES WITH CYCLOALKYL AND POLYCYCLOALQUIL, ALPHA-SUBSTITUTED WITH ARYL AND HETEROARYL AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM - Google Patents

PROCESS FOR THE PREPARATION OF N-SUBSTITUTED NON-SUBSTITUTED PHENYLALANYL AND PHYETHYLAMINE DERIVATIVES WITH CYCLOALKYL AND POLYCYCLOALQUIL, ALPHA-SUBSTITUTED WITH ARYL AND HETEROARYL AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM

Info

Publication number
PT98842A
PT98842A PT98842A PT9884291A PT98842A PT 98842 A PT98842 A PT 98842A PT 98842 A PT98842 A PT 98842A PT 9884291 A PT9884291 A PT 9884291A PT 98842 A PT98842 A PT 98842A
Authority
PT
Portugal
Prior art keywords
substituted
polycycloalquil
phyethylamine
phenylalanyl
heteroaryl
Prior art date
Application number
PT98842A
Other languages
Portuguese (pt)
Other versions
PT98842B (en
Inventor
David Christopher Herwell
David Charles Rees
Reginald Stewart Richardsen
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of PT98842A publication Critical patent/PT98842A/en
Publication of PT98842B publication Critical patent/PT98842B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/595—Gastrins; Cholecystokinins [CCK]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/20—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • C07K5/06156—Dipeptides with the first amino acid being heterocyclic and Trp-amino acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
PT98842A 1990-08-31 1991-08-30 PROCESS FOR THE PREPARATION OF N-SUBSTITUTED NON-SUBSTITUTED PHENYLALANYL AND PHYETHYLAMINE DERIVATIVES WITH CYCLOALKYL AND POLYCYCLOALQUIL, ALPHA-SUBSTITUTED WITH ARYL AND HETEROARYL AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM PT98842B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57662890A 1990-08-31 1990-08-31
US72665591A 1991-07-12 1991-07-12

Publications (2)

Publication Number Publication Date
PT98842A true PT98842A (en) 1992-08-31
PT98842B PT98842B (en) 1999-01-29

Family

ID=27077012

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98842A PT98842B (en) 1990-08-31 1991-08-30 PROCESS FOR THE PREPARATION OF N-SUBSTITUTED NON-SUBSTITUTED PHENYLALANYL AND PHYETHYLAMINE DERIVATIVES WITH CYCLOALKYL AND POLYCYCLOALQUIL, ALPHA-SUBSTITUTED WITH ARYL AND HETEROARYL AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM

Country Status (9)

Country Link
EP (1) EP0547178A4 (en)
JP (1) JPH06502627A (en)
KR (1) KR100222634B1 (en)
CA (1) CA2088195A1 (en)
IE (1) IE67290B1 (en)
NO (1) NO312298B1 (en)
NZ (1) NZ239595A (en)
PT (1) PT98842B (en)
WO (1) WO1992004045A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5217957A (en) * 1991-08-20 1993-06-08 Warner-Lambert Company Cholecystokinin antagonists useful for treating depression
US5380872A (en) * 1992-07-14 1995-01-10 Glaxo Inc. Modulators of cholecystokinin
AU5975094A (en) * 1993-02-03 1994-08-29 Fisons Corporation 1,2,4-triazinone derivatives and their use in therapy
GB9304500D0 (en) * 1993-03-05 1993-04-21 Glaxo Spa Heterocyclic compounds
US6194437B1 (en) 1996-08-22 2001-02-27 Warner-Lambert Company Non-peptide bombesin receptor antagonists
US6645968B2 (en) 1999-08-03 2003-11-11 Abbott Laboratories Potassium channel openers
US6846836B2 (en) 2003-04-18 2005-01-25 Bristol-Myers Squibb Company N-substituted phenylurea inhibitors of mitochondrial F1F0 ATP hydrolase
JP2007504171A (en) 2003-08-29 2007-03-01 ザ ブライハム アンド ウイメンズ ホスピタル， インコーポレイテッド Cell necrosis inhibitor
JP2010503709A (en) * 2006-09-15 2010-02-04 レビバ ファーマシューティカルズ，インコーポレーテッド Synthesis, methods of use and compositions of cycloalkylmethylamines
US20120122889A1 (en) 2008-12-23 2012-05-17 President And Fellows Of Harvard College Small molecule inhibitors of necroptosis
GB0919194D0 (en) 2009-11-02 2009-12-16 Lytix Biopharma As Compounds
WO2012003501A2 (en) 2010-07-02 2012-01-05 Reviva Pharmaceuticals, Inc. Compositions, synthesis, and methods of using cycloalkylmethylamine derivatives
US9725452B2 (en) 2013-03-15 2017-08-08 Presidents And Fellows Of Harvard College Substituted indoles and pyrroles as RIP kinase inhibitors
WO2016094846A1 (en) 2014-12-11 2016-06-16 President And Fellows Of Harvard College Inhibitors of cellular necrosis and related methods

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4757151A (en) * 1985-11-14 1988-07-12 Warner-Lambert Company 2-substituted-[2-substituted-amino]-N-arylalkyl-3-[indol-3-yl]
CA1291031C (en) * 1985-12-23 1991-10-22 Nikolaas C.J. De Jaeger Method for the detection of specific binding agents and their correspondingbindable substances
US4814463A (en) * 1985-12-31 1989-03-21 Biomeasure, Inc. CCK antagonists
FR2606963B1 (en) * 1986-11-14 1989-01-13 Cit Alcatel SUBMARINE REPEATER BOX
EP0336356A3 (en) * 1988-04-05 1991-09-25 Abbott Laboratories Derivatives of tryptophan as cck antagonists
NZ234264A (en) * 1989-06-29 1993-05-26 Warner Lambert Co N-substituted cycloalkyl and polycycloalkyl alpha-substituted trp-phe- and phenethylamine derivatives, and pharmaceutical compositions
US5244915A (en) * 1990-08-31 1993-09-14 Warner-Lambert Company Amico acid derivatives cyclized at the c-terminal

Also Published As

Publication number Publication date
KR930703349A (en) 1993-11-29
EP0547178A4 (en) 1994-07-06
NO930709D0 (en) 1993-02-26
JPH06502627A (en) 1994-03-24
IE67290B1 (en) 1996-03-20
PT98842B (en) 1999-01-29
WO1992004045A1 (en) 1992-03-19
EP0547178A1 (en) 1993-06-23
NZ239595A (en) 1994-06-27
AU651390B2 (en) 1994-07-21
CA2088195A1 (en) 1992-03-01
AU8749291A (en) 1992-03-30
KR100222634B1 (en) 1999-10-01
NO930709L (en) 1993-04-15
IE913077A1 (en) 1992-03-11
NO312298B1 (en) 2002-04-22

Similar Documents

Publication Publication Date Title
PT99227A (en) PROCESS FOR THE PREPARATION OF QUINAZOLINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
PT99671A (en) Process for the preparation of N-O-SULFATED HEPAROSANES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
PT98369A (en) PROCESS FOR THE PREPARATION OF SUBSTITUTED AZOYS AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM
PT93094A (en) PROCESS FOR THE PREPARATION OF SUBSTITUTED 1,3-OXATIOLANES AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM
PT90662A (en) PROCESS FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS CONTAINING ARILMETILENYL DERIVATIVES OF THIAZOLIDINONES, IMIDAZOLIDINONES AND UXO OXAZOLIDINONES AS ANTIALERGIC AGENTS AND ANTI-INFLAMMATORY AGENTS
PT92497A (en) PROCESS FOR THE PREPARATION OF UREIA DERIVATIVES OF ENZYME INHIBITING DIPEPTIDEES, AND OF PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
BR1100850A (en) Compound, process for the preparation of a compound, and pharmaceutical composition
PT89661A (en) PROCESS FOR THE PREPARATION OF SUBSTITUTED PYRROLIC COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
PT98696A (en) PROCESS FOR THE PREPARATION OF VALINAMIDE DERIVATIVES SUBSTITUTED WITH FUNGICIDE EFFECT
PT97363A (en) PROCESS FOR PREPARING SUBSTITUTED BENZIMIDAZOLES AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM
PT98842A (en) PROCESS FOR THE PREPARATION OF N-SUBSTITUTED NON-SUBSTITUTED PHENYLALANYL AND PHYETHYLAMINE DERIVATIVES WITH CYCLOALKYL AND POLYCYCLOALQUIL, ALPHA-SUBSTITUTED WITH ARYL AND HETEROARYL AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM
PT97114A (en) PROCESS FOR THE PREPARATION OF HIDANTOIN DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
PT98529A (en) METHOD FOR THE PREPARATION OF ACETAMIDE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
BR9103036A (en) COMPOUND, PHARMACEUTICAL FORMULATION AND PROCESS FOR THE PREPARATION OF COMPOUND
PT98365A (en) METHOD FOR PREPARING NEW OXALYL DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
PT91701A (en) PROCESS FOR THE PREPARATION OF ORGANIC NITRATE ESTERS AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM, HAVING RELAXING ACTIVITY
PT93067A (en) PROCESS FOR THE PREPARATION OF ALPHATIC 2-HYDROXYACIDES DERIVATIVES AND 1-BENZYL-3-HYDROXYMETHYLINDAZOLE ETERES, AND OF PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM
MX9205155A (en) N-SUBSTITUTED HETERO CYCLIC DERIVATIVES, PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITION CONTAINING THEM.
PT89486A (en) PROCESS FOR THE PREPARATION OF VITAMIN D3 16-DEHYDRO DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM
PT90017A (en) PROCESS FOR THE PREPARATION OF ARILPIPERAZINILALCOXI DERIVATIVES OF CYCLIC IMIDAS AND A PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM
PT93290A (en) METHOD FOR PREPARING NEW HETEROCYCLIC ETERS AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM
PT90563A (en) A process for the preparation of 3- (N-METEROCYCLYL) -2,6-DIAMINOPYRIDINES AND SUBSTITUTED N-OXIDES AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM
PT94629A (en) PROCESS FOR THE PREPARATION OF CHROMATE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
PT90841A (en) PROCESS FOR THE PREPARATION OF PIROL DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
PT90530A (en) 1,1-DIOXO-CEFEM-4-CARBOTIOLIC ACID AND PHARMACEUTICAL OR VETERINARY COMPOUNDS WHICH CONTAIN THESE DERIVATIVES AND PROCESS FOR THE PREPARATION OF DERIVATIVES

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19920424

FG3A Patent granted, date of granting

Effective date: 19981030

MM3A Annulment or lapse

Effective date: 20060502